Home 2018
Archives
AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis
AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention
Second study shows no significant results for vitamin D supplementation versus placebo
Naloxone Products Stay Effective Long After Expiration Date
Narcan, Evzio chemically stable for at least 10 to 12 months after listed expiration dates
Fluorescence Can ID High-Grade Glioma During Sx for Brain Tumor
Visible fluorescence shows presence of high-grade glioma cells within tumor mass during surgery
Low-Dose Radiation Safe for Low-Risk Thyroid Cancer
No increased risk for recurrence with 1.1 GBq versus 3.7 GBq RAI at 3-, 5-, 7-year follow-up
AAP Warns of Harms of Corporal Punishment for Children
Parents are encouraged to use healthy forms of discipline such as positive reinforcement
AHA: Opioid Use Appears to Up Risk for Atrial Fibrillation
Opioid prescription independently tied to likelihood of having atrial fibrillation in cohort of young veterans
AHA: Public Automated External Defibrillators Are Cost-Effective
Second study shows improved one-month survival with favorable neurological outcome with public AED use
Cancer Mortality Up for 2nd-, 3rd-Generation Latino Immigrants
Latino generation linked to cancer mortality risk after adjustment for education, lifestyle factors, illness
Poll: Patients, Caregivers Worry About Cost of Cancer Care
Survey also shows that Americans misinformed about alternative treatments for cancer
